|
CAST expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.46979999999342E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.097500E-03 |
| Normal-vs-Stage2 |
2.233800E-01 |
| Normal-vs-Stage3 |
4.232300E-04 |
| Normal-vs-Stage4 |
1.656250E-03 |
| Stage1-vs-Stage2 |
4.989600E-01 |
| Stage1-vs-Stage3 |
1.905370E-01 |
| Stage1-vs-Stage4 |
2.316400E-02 |
| Stage2-vs-Stage3 |
1.535840E-01 |
| Stage2-vs-Stage4 |
1.621740E-02 |
| Stage3-vs-Stage4 |
8.100100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18909999999406E-05 |
| Normal-vs-AfricanAmerican |
1.123950E-02 |
| Normal-vs-Asian |
2.817700E-03 |
| Caucasian-vs-AfricanAmerican |
5.955000E-01 |
| Caucasian-vs-Asian |
8.268200E-01 |
| AfricanAmerican-vs-Asian |
6.655200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.324300E-03 |
| Normal-vs-Female |
5.67229999999252E-05 |
| Male-vs-Female |
9.835200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.780200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.381900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.486290E-02 |
| Normal-vs-Age(81-100Yrs) |
6.988000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.020800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.513400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.856000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.970200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.407000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.712850E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.057440E-01 |
| Classical-VS-Follicular |
1.77402537104854E-12 |
| Classical-VS-Other |
2.171000E-01 |
| Classical-VS-Normal |
5.8277999981371E-08 |
| Tall-VS-Follicular |
1.1454004411604E-10 |
| Tall-VS-Other |
1.590030E-02 |
| Tall-VS-Normal |
2.33930000004268E-06 |
| Follicular-VS-Other |
3.739400E-01 |
| Follicular-VS-Normal |
5.077600E-02 |
| Other-VS-Normal |
9.075000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.091630E-01 |
| Normal-vs-N1 |
3.143600E-03 |
| N0-vs-N1 |
2.187700E-02 |
|
|
